Supriya Lifescience Balance Sheet Health
Financial Health criteria checks 6/6
Supriya Lifescience has a total shareholder equity of ₹8.2B and total debt of ₹54.9M, which brings its debt-to-equity ratio to 0.7%. Its total assets and total liabilities are ₹9.2B and ₹1.1B respectively. Supriya Lifescience's EBIT is ₹1.7B making its interest coverage ratio 107.1. It has cash and short-term investments of ₹749.6M.
Key information
0.7%
Debt to equity ratio
₹54.88m
Debt
Interest coverage ratio | 107.1x |
Cash | ₹749.56m |
Equity | ₹8.15b |
Total liabilities | ₹1.06b |
Total assets | ₹9.21b |
Recent financial health updates
No updates
Recent updates
Supriya Lifescience (NSE:SUPRIYA) Has Announced That It Will Be Increasing Its Dividend To ₹0.80
Sep 08We Think You Should Be Aware Of Some Concerning Factors In Supriya Lifescience's (NSE:SUPRIYA) Earnings
Jun 05Little Excitement Around Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings
May 10Lacklustre Performance Is Driving Supriya Lifescience Limited's (NSE:SUPRIYA) Low P/E
Feb 09Supriya Lifescience's (NSE:SUPRIYA) Shareholders May Want To Dig Deeper Than Statutory Profit
May 28Market Cool On Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings Pushing Shares 27% Lower
May 07Financial Position Analysis
Short Term Liabilities: SUPRIYA's short term assets (₹4.0B) exceed its short term liabilities (₹768.9M).
Long Term Liabilities: SUPRIYA's short term assets (₹4.0B) exceed its long term liabilities (₹289.8M).
Debt to Equity History and Analysis
Debt Level: SUPRIYA has more cash than its total debt.
Reducing Debt: SUPRIYA's debt to equity ratio has reduced from 81.8% to 0.7% over the past 5 years.
Debt Coverage: SUPRIYA's debt is well covered by operating cash flow (2064.6%).
Interest Coverage: SUPRIYA's interest payments on its debt are well covered by EBIT (107.1x coverage).